162 related articles for article (PubMed ID: 6033236)
1. Is cervical carcinoma in situ a significant lesion?
Green GH
Int Surg; 1967 Jun; 47(6):511-7. PubMed ID: 6033236
[No Abstract] [Full Text] [Related]
2. Cervical cancer screening: précis and critique of a recent Canadian report.
Chiavetta J; Leader SR
Med J Aust; 1977 Jan 1-8; 1(1-2):23-8. PubMed ID: 840075
[No Abstract] [Full Text] [Related]
3. The therapy and follow-up of in situ and microinvasive carcinoma of the cervix.
Lash AF
Int Surg; 1967 Jun; 47(6):518-27. PubMed ID: 6033237
[No Abstract] [Full Text] [Related]
4. The progression of pre-invasive lesions of the cervix to invasion.
Green GH
N Z Med J; 1974 Oct; 80(525):279-87. PubMed ID: 4531563
[No Abstract] [Full Text] [Related]
5. Cytology screening--a program that works.
MacLean MA
Can Nurse; 1969 May; 65(5):40-3. PubMed ID: 5769363
[No Abstract] [Full Text] [Related]
6. [On the treatment of Ca in situ of the uterine cervix].
Svindler EA; Leibman IuIa
Vopr Onkol; 1967; 13(7):39-44. PubMed ID: 5598968
[No Abstract] [Full Text] [Related]
7. [Cytologic screening--an effective method].
MacLean MA
Infirm Can; 1970 Feb; 12(2):23-7. PubMed ID: 5197343
[No Abstract] [Full Text] [Related]
8. The significance of cervical carcinoma in situ.
Green GH
Aust N Z J Obstet Gynaecol; 1966 Feb; 6(1):42-4. PubMed ID: 5218310
[No Abstract] [Full Text] [Related]
9. The changing patterns of cervix cancer.
Christopherson WM
CA Cancer J Clin; 1971; 21(5):283-7. PubMed ID: 4999532
[No Abstract] [Full Text] [Related]
10. Detection of cervical cancer by cytologic screening: period, 1948-1953 and 1958-1963.
Tilden IL; Nishimura JK
Pac Med Surg; 1966; 74(1):53-5. PubMed ID: 5904449
[No Abstract] [Full Text] [Related]
11. The significance of cervical carcinoma in situ.
Green GH
Am J Obstet Gynecol; 1966 Apr; 94(7):1009-22. PubMed ID: 5910357
[No Abstract] [Full Text] [Related]
12. [The significance of cytodiagnosis as a screening method in the domain of early diagnosis of cervix cancer and its early stages for the general practioner].
Bötzelen HP; Meyer K
Z Allgemeinmed; 1964 Dec; 40(36):1549-51. PubMed ID: 5889485
[No Abstract] [Full Text] [Related]
13. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
14. False negative rate in mass screening for cervical cancer.
Sato S; Mikino H; Matsunaga G; Yajima A
Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
[No Abstract] [Full Text] [Related]
15. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
Simcock B; Sykes P; Laney M
N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
[TBL] [Abstract][Full Text] [Related]
16. [Positive cytology of the cervix, its histological clarification and the following choice of treatment].
Michalzik K; Ober KG
Geburtshilfe Frauenheilkd; 1966 Feb; 26(2):202-22. PubMed ID: 5982485
[No Abstract] [Full Text] [Related]
17. Two-wavelength Feulgen cytophotometry of cells exfoliated from the uterine cervix.
Hrushovetz SB
Acta Cytol; 1969 Oct; 13(10):583-94. PubMed ID: 4186897
[No Abstract] [Full Text] [Related]
18. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
Klinkhamer PJ; van der Graaf Y; Vooijs GP
Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
[No Abstract] [Full Text] [Related]
19. The cytological diagnosis of carcinoma in situ.
Ward JG
J S C Med Assoc; 1966 Oct; 62(10):389-92. PubMed ID: 5232376
[No Abstract] [Full Text] [Related]
20. [Flow & image cytometry and clinical applications in cancer diagnosis].
Nishiya I; Izutsu T
Rinsho Byori; 1993 Jun; Suppl 94():51-65. PubMed ID: 8361009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
